Prevention of Drug Absorption in Simulated Theophylline Overdose

References

• Gaudreault P, Guay J. Theophylline poisoning. Pharmacological considerations and clinical management. Med Toxicol 1986; 1: 169–191
   PubMedGoogle Scholar
• Robertson N J. Fatal overdose from a sustained-release theophylline preparation. Ann Emerg Med 1985; 14: 154–158
   PubMed Web of Science ®Google Scholar
• Eason J, Markowe H L. Aminophylline toxicity-how many hospital asthma deaths does it cause. Respir Med 1989; 83: 219–226
   PubMed Web of Science ®Google Scholar
• Jusko W J, Gardner M J, Mangione A, et al. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates and ethanol. J Pharm Sci 1979; 68: 1358–1366
   PubMed Web of Science ®Google Scholar
• Upton R A. Pharmacokinetic interactions between theophylline and other medication (Part I). Clin Pharmacokinet 1991; 20: 66–80
   PubMed Web of Science ®Google Scholar
• Upton R A. Pharmacokinetic interactions between theophylline and other medication (Part II). Clin Pharmacokinet 1991; 20: 135–150
   PubMed Web of Science ®Google Scholar
• Comstock E G, Faulkner T P, Boisaubin E V, Olson D A, Comstock B S. Studies on the efficacy of gastric lavage as practiced in a large metropolitan hospital. Clin Toxicol 1981; 18: 581–597
   PubMed Web of Science ®Google Scholar
• Danel V, Henery J A, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J 1988; 296: 1507
   PubMed Web of Science ®Google Scholar
• Gal P, Miller A, McCue J D. Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA 1984; 251: 3130–3131
   PubMed Web of Science ®Google Scholar
• Tenenbein M. Inefficacy of gastric emptying procedures. J Emerg Med 1985; 3: 133–136
   PubMedGoogle Scholar
• Tenenbein M, Cohen S, Sitar D S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charocoal for acute durg overdose. Ann Emerg Med 1987; 16: 838–841
   PubMed Web of Science ®Google Scholar
• Vale J A, Meredith T J, Proudfoot A T. Syrup of ipeacauanha: is it really useful. Br Med J 1986; 293: 1321–1322
   PubMed Web of Science ®Google Scholar
• Minton N A, Henry J A, Glucksman E, et al. An investigation into methods of prevention of theophylline absorption from accidental or deliberate overdose. Eur J Clin Pharmacol 1989; 36(Suppl)A95
   Google Scholar
• Chiou W L. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokinet Biopharm 1978; 6: 539–546
   PubMedGoogle Scholar
• Pond S M. Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol 1986; 1: 3–11
   PubMedGoogle Scholar
• Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 1982; 307: 676–678
   PubMed Web of Science ®Google Scholar
• Berlinger W G, Spector R, Goldberg M J, et al. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 1983; 33: 351–354
   PubMed Web of Science ®Google Scholar
• Goldberg M J, Spector R, Park G D, Johnson G F, Roberts P. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline. Clin Pharmacol Ther 1987; 41: 108–111
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K, Yealy D M, Krenzelok E P. The comparative efficacy of various multiple-dose activated charcoal regimens. Am J Emerg Med 1992; 10: 298–300
   PubMed Web of Science ®Google Scholar
• Lim D T, Singh P, Nourtsis S, Dela Cruz R D. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med 1986; 15: 1303–1307
   PubMed Web of Science ®Google Scholar
• Mahutte C K, True R J, Michiels T M, Berman J M, Light R W. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev Respir Dis 1983; 128: 820–822
   PubMed Web of Science ®Google Scholar
• Park G D, Radomski L, Goldberg M J, et al. Effects of the size and frequency of oral doses of charcoal on theophylline clearance. Clin Pharmacol Ther 1983; 34: 663–666
   PubMed Web of Science ®Google Scholar
• Radomski L, Park G D, Goldberg M J, et al. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther 1984; 35: 402–408
   PubMed Web of Science ®Google Scholar
• Rygnestad T., Walstad R A, Dahl K. Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination. Acta Med Scand 1986; 219: 425–427
   PubMed Web of Science ®Google Scholar
• Shannon M, Amitai Y, Lovejoy FH, Jr. Multiple dose activated charcoal for theophylline poisoning in young infants. Pediatr 1987; 80: 368–370
   PubMed Web of Science ®Google Scholar
• True R J, Berman J M, Mahutte C K. Treatment of theophylline overdose with oral activated charcoal. Crit Care Med 1984; 12: 113–114
   PubMed Web of Science ®Google Scholar
• Krenzelok E P, Keller R, Stewart R D. Gastrointestinal transit times of cathartics combined with charcoal. Ann Emerg Med 1985; 14: 1152–1155
   PubMed Web of Science ®Google Scholar
• Al-Shareef A H, Buss D, Allen E M, Routledge P A. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Human Exp Toxicol 1990; 9: 179–182
   PubMed Web of Science ®Google Scholar
• McNamara R M, Aaron C K, Gemborys M, Davidheiser S. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose. Ann Emerg Med 1988; 17: 243–246
   PubMed Web of Science ®Google Scholar
• Watson W A, Cremer K F, Chapman J A. Gastrointestinal obstruction associated with multiple dose of activated charcoal. J Emerg Med 1986; 4: 401–407
   PubMedGoogle Scholar
• Rosenberg P J, Livingstone D J, McLellan B A. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal. Ann Emerg Med 1988; 17: 681–683
   PubMed Web of Science ®Google Scholar
• van de Graff W B, Thompson W L, et al. Absorbent and cathartic inhibition of enteral drug absorption. J Pharmacol Exp Ther 1982; 221: 656–663
   PubMed Web of Science ®Google Scholar
• Henderson A, Wright D M, Pond S M. Management of theophylline overdose patients in the Intensive Care Unit. Anaesth Intensive Care 1992; 20: 56–62
   PubMed Web of Science ®Google Scholar
• Amitai Y, Lovejoy FH, Jr. Characteristics of vomiting associated with sustained release theophylline poisoning: implications for management with oral activated charcoal. Clin Toxicol 1987; 25: 539–554
   Web of Science ®Google Scholar
• Sessler C N. Poor tolerance of oral activated charcoal with theophylline overdose. Am J Emerg Med 1987; 5: 492–495
   PubMed Web of Science ®Google Scholar
• Amitai Y, Yeung A C, Moye J, Lovejoy FH, Jr. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Ann Intern Med 1986; 105: 386–387
   PubMed Web of Science ®Google Scholar
• Ohning B L, Reed M D, Blumer J L. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Pediatr Pharmacol 1986; 5: 241–245
   PubMedGoogle Scholar
• Brown S G, Prentice D A. Ondansetron in the treatment of theophylline overdose. Med J Austr 1992; 156: 512
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Olkkola K T. Effect of purgatives on antidotal efficacy of oral activated charcoal. Hum Toxicol 1986; 5: 255–263
   PubMedGoogle Scholar
• Jefferys D B, Raper S M, Helliwell M, Berry D J, Crome P. Haemoperfusion for theophylline overdose. Br Med J 1980; 280: 1167
   PubMed Web of Science ®Google Scholar